Memantine attenuates the development of osteoarthritis by blocking NMDA receptor mediated calcium overload and chondrocyte senescence

Background: Memantine, which is an FDA-proven drug for the treatment of dementia, exerts its function by blocking the function of NMDA (N-methyl-D-aspartate) receptor, a calcium-permeable ion channel that reduces cytotoxic calcium overload. Chondrocyte senescence is a crucial cellular event that con...

全面介紹

書目詳細資料

Principais autores:	Qingmei Cheng, Ke He, Junyu Zhu, Xiaoxiao Li, Xuan Wu, Chao Zeng, Guanghua Lei, Ning Wang, Hui Li, Jie Wei
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2024-09-01
叢編:	Journal of Orthopaedic Translation
主題:	Chondrocyte senescence Memantine Mitochondria NMDA receptor Osteoarthritis
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2214031X24000949
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!